JEFFERY BRYANT: Open Payments
NPI 1285156737 · SOUTHFIELD, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,249 in 15 payments from 5 companies in 2025. Trend: 2023 $132 · 2024 $462 · 2025 $1,249
Food & beverage: $1,249
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 8 | $392 |
| AKEBIA THERAPEUTICS INC | 3 | $368 |
| Novo Nordisk Inc | 2 | $242 |
| GENZYME CORPORATION | 1 | $126 |
| Gilead Sciences, Inc. | 1 | $122 |
Products named: Vafseo, XPHOZAH 30 MG, Ozempic, IBSRELA, CEREZYME, Epclusa.
Industry payments across MI — which companies pay providers there.
